Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy

被引:0
|
作者
J. Choi
S. Pai
机构
[1] Department of Clinical Pathology,
[2] College of Medicine,undefined
[3] Inha University Hospital,undefined
[4] 7–206,undefined
[5] 3-ga,undefined
[6] Shinheung-dong,undefined
[7] Jung-gu,undefined
[8] Inchon 400–103,undefined
[9] Republic of Korea,undefined
来源
Annals of Hematology | 2002年 / 81卷
关键词
Coagulation factors Fibrinogen Pregnancy Tissue plasminogen activator;
D O I
暂无
中图分类号
学科分类号
摘要
To investigate the relationship between coagulation activities and the fibrinolytic system during normal pregnancy, we measured the plasma concentrations of coagulation factors, antithrombin III (AT III), D-dimer, tissue plasminogen activator (tPA), total protein S (TPS), and plasminogen activator inhibitor type 1 (PAI-1) in 436 apparently healthy pregnant, postpartum, and nonpregnant women. There were no significant changes in AT III, TPS, and factor XI concentrations during pregnancy and puerperium. However, factor VII, VIII, IX, and XII activities increased gradually as pregnancy progressed, reached maximum values in the third trimester, and returned to nonpregnant levels by 5–8 weeks postpartum. Plasma D-dimer levels in the third trimester of pregnancy were 1.23±0.42 µg/ml, significantly higher than for the first trimester (0.34±0.16 µg/ml, P<0.01). The tPA antigen levels averaged 1.8-fold higher in the late third trimester than in the first trimester; the plasma fibrinogen concentrations averaged 1.6-fold higher in the late third trimester than in the first trimester. Compared to the peak values during pregnancy, tPA levels averaged 39.8% lower and plasma fibrinogen concentrations averaged 40.0% lower at 5–8 weeks postpartum. The tPA levels correlated strongly with the plasma fibrinogen concentrations (r=0.52, P<0.01). In short, this study shows that tPA levels change in parallel with plasma fibrinogen concentrations during and after normal pregnancy.
引用
收藏
页码:611 / 615
页数:4
相关论文
共 50 条
  • [41] Tissue plasminogen activator plasma levels are related with central adiposity in patients with essential hypertension
    Rivera, M.
    Morillas, P.
    Juanatey, J. R.
    Rosello-Lleti, E.
    de Burgos, F. Garcia
    Soria, F.
    Mora, V.
    Grigorian, L.
    Martinez-Dolz, L.
    Calabuig, J. R.
    Mainar, L.
    Orosa, P.
    Cortes, R.
    Paya, R.
    Bertomeu, V.
    JOURNAL OF HYPERTENSION, 2007, 25 : S83 - S83
  • [42] PLASMA TISSUE PLASMINOGEN-ACTIVATOR LEVELS IN PATIENTS WITH CORONARY HEART-DISEASE
    VANDEKERCKHOVE, Y
    BAELE, G
    DEPUYDT, H
    WEYNE, A
    CLEMENT, D
    THROMBOSIS RESEARCH, 1988, 50 (03) : 449 - 453
  • [43] PLASMA PLASMINOGEN-ACTIVATOR LEVELS INCREASE PROGRESSIVELY DURING PROLONGED EXERCISE
    VANLOON, BJP
    HEERE, LP
    KLUFT, C
    BRIET, E
    DOOIJEWAARD, G
    MEINDERS, AE
    FIBRINOLYSIS, 1990, 4 : 102 - 104
  • [44] ENHANCEMENT OF PLASMINOGEN ACTIVATION BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN THE PRESENCE OF ANCROD AND FIBRINOGEN
    REDDY, KNN
    CERCEK, B
    GANZ, W
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 436 - 436
  • [45] Specific elevation in plasma tissue plasminogen activator antigen concentrations in South Asians relative to Europeans
    Forouhi, NG
    Rumley, A
    Lowe, GD
    McKeigue, P
    Sattar, N
    BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (08) : 755 - 760
  • [46] BINDING OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN TO FIBRINOGEN AND ITS DEGRADATION PRODUCTS
    BOSMA, PJ
    RIJKEN, DC
    NIEUWENHUIZEN, W
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 436 - 436
  • [47] In vitro plasminogen activation by joint action of the tissue plasminogen activator and a urokinase-fibrinogen conjugate
    Maksimenko A.V.
    Tishchenko E.G.
    Dobrovol'skii A.B.
    Pharmaceutical Chemistry Journal, 1998, 32 (4) : 171 - 175
  • [48] Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait
    Akanji, AO
    Abdullah, A
    Tahzeeb, S
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (05) : 380 - 386
  • [49] Thrombolysis by recombinant tissue plasminogen activator during pregnancy: a case of massive pulmonary embolism
    Lonjaret, Laurent
    Lairez, Olivier
    Galinier, Michel
    Minville, Vincent
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2011, 29 (06): : 694.e1 - 694.e2
  • [50] Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator
    Lee, Kevin
    Istl, Alexandra
    Dubois, Luc
    DeRose, Guy
    Forbes, Thomas L.
    Wiseman, Daniele
    Mujoomdar, Amol
    Kribs, Stewart
    Power, Adam H.
    VASCULAR AND ENDOVASCULAR SURGERY, 2015, 49 (07) : 175 - 179